APPEAL Project Annual Meeting Held in Barcelona
25 Nov 25
Last week, the partners of the APPEAL project gathered in person for the second time, marking a major milestone in
Last week, the partners of the APPEAL project gathered in person for the second time, marking a major milestone in
Leitat successfully concluded its participation in MEDICA 2025, the world’s leading trade fair for medical technology, held from November 17
La certificació, atorgada per AENOR, consolida l’entitat com a agent clau en innovació sanitària a l’Estat, garantint el màxim estàndard
The iDIABETES project has developed two non-invasive devices to measure glucose in sweat and saliva. The one designed by Leitat,
From November 17 to 20, Leitat will participate in MEDICA 2025, the world’s leading trade fair for medical technology, held
On October 10, the EGFR-LYTAC project consortium met in person at the facilities of the Center for Genomic Regulation (CRG),
Leitat has been recognised with the Innovation Capacity Award from the Vilanova del Camí City Council, granted within the framework
The partners of the LiquiDx project gathered on 18 September 2025 at the Biobanco del Sistema Sanitario Público de Andalucía
The European project IN-ARMOR, focused on advancing innovative strategies to combat antimicrobial resistance (AMR), held its 3rd Consortium Meeting in
On October 2–3, the Università degli Studi di Pavia hosted the Kick-off Meeting for the TEN4CARE Project (Tendon Engineering for
Cancer immunotherapy, also known as immuno-oncology, represents one of the greatest revolutions in cancer treatment in recent decades. This therapeutic
On 21st November 2024, the SBR consortium gathered online for its final meeting, marking the conclusion of more than five
El projecte va obtenir un finançament de 985.000 € per part de l’Agència Estatal d’Investigació i reuneix un consorci de
Osteoarticular osteoarthritis is a chronic degenerative disease that affects the joints, particularly in older individuals, negatively impacting their quality of
On February 14, 2025, the kick-off meeting (KOM) of the VAGINEF project took place at the Vall d’Hebron Research Institute
The biopharmaceutical company ONCOMATRYX Biopharma and Leitat are collaborating in the NEXTOM project, which aims to develop new Antibody Drug
Phone. (+34) 937 882 300
